Funds and ETFs Orion Oyj

ORNBV

FI0009014377

Name	Weight	AuM	1st Jan change	Investor Rating
XACT NORDIC HIGH DIVIDEND LOW VOLATILITY UCITS ETF - SEK	2.96%	664 M€	+11.29%
SELIGSON & CO OMX HELSINKI 25 UCITS ETF - EUR	2.87%	473 M€	+6.93%
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.35%	1,083 M€	+4.23%
FRANKLIN LIBERTYQ EUROPEAN EQUITY UCITS ETF - EUR	0.32%	3 M€	+9.95%	-
INDEXIQ FACTORS SUSTAINABLE EMU EQUITY UCITS ETF - EUR	0.24%	2 M€	+11.91%
ISHARES EDGE MSCI MULTIFACTOR EAFE INDEX ETF (CAD-HEDGED) - CAD	0.14%	5 M€	+10.09%	-
ISHARES EDGE MSCI MULTIFACTOR EAFE INDEX ETF - CAD	0.14%	14 M€	+5.66%	-
HARTFORD MULTIFACTOR DIVERSIFIED INTERNATIONAL ETF - USD	0.12%	17 M€	+5.14%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.11%	17 M€	+7.01%	-
AMUNDI MSCI EUROPE EX UK UCITS ETF (C) - EUR	0.07%	6 M€	-.--%	-
UBS (IRL) ETF PLC MSCI EUROPE ESG UNIVERSAL LOW CARBON SELECT UCITS ETF - ACC - EUR	0.03%	6 M€	-.--%
SIMPLIFY DEVELOPED EX-US PLUS DOWNSIDE CONVEXITY ETF - USD	0.02%	10 M€	-3.35%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.02%	187 M€	+9.41%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.02%	264 M€	-.--%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.02%	477 M€	+12.11%
AMUNDI MSCI WORLD ESG LEADERS SELECT - UCITS ETF DR (C) - USD	0.02%	276 M€	+11.40%	-
AMUNDI INDEX MSCI WORLD UCITS ETF DR (D) - EUR	0.01%	607 M€	+0.05%	-
AMUNDI INDEX MSCI WORLD UCITS ETF - EUR	0.01%	1,166 M€	+0.26%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.01%	391 M€	+8.80%	-
AMUNDI MSCI WORLD CLIMATE PARIS ALIGNED PAB UCITS ETF DR (C) - USD	0.01%	284 M€	-.--%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (UNHEDGED) ETF - JPY	0.01%	283 M€	+19.85%
LYXOR MSCI WORLD CLIMATE CHANGE (DR) UCITS ETF - ACC - USD	0.01%	206 M€	-.--%
RAREVIEW SYSTEMATIC EQUITY ETF - USD	0.01%	45 M€	0.00%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR	0.01%	105 M€	+3.97%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	34 M€	+8.23%	-

Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Ratings for Orion Oyj

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

37.49 EUR

Average target price

39 EUR

Spread / Average Target

+4.03%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ORION OYJ	-3.36%	5.71B
NOVO NORDISK A/S	+31.69%	588B
JOHNSON & JOHNSON	-3.20%	364B
MERCK & CO., INC.	+19.54%	326B
ABBVIE INC.	+5.07%	285B
ASTRAZENECA PLC	+15.55%	239B
NOVARTIS AG	+10.18%	210B
ROCHE HOLDING AG	-7.20%	200B
AMGEN INC.	+8.95%	167B
PFIZER, INC.	-0.47%	161B

Other Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 10:26:28 2024-05-15 am EDT			5-day change	1st Jan Change
37.82 ^EUR	+0.89%		+4.26%	-3.36%

May. 07	Orion Corporation Announces Change in Orion Group Executive Management Board as of 31 May 2025	CI
Apr. 26	Orion Corporation Announces Appointments to Nomination Committee	CI